Cytrx reported 6.49M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Brainstorm Cell Therapeutics BCLI:US $ 30.17M 6.03M
Celldex Therapeutics CLDX:US $ 182.28M 11.88M
Curis CRIS:US $ 112.47M 9.44M
Cytrx CYTR:US 6.49M 1.1M
Glaxosmithkline GSK:US $ 15377M 512M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Northwest Biotherapeutics NWBO:US -349842000 3.36M
Novartis NVS:US $ 54042M 3519M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Takeda 4502:JP Y 5299774M 126737M